Mode
Text Size
Log in / Sign up
N/A N=54 Randomized Double-blind Health Services Research

Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI)

Insomnia · Depression · Posttraumatic Stress Disorder · Suicidal Ideation

Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcome: Primary: Columbia Suicide Severity Rating Scale (C-SSRS) — 5.4; 8.4 units on a scale — p=.153

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CBT-I (Behavioral); TAU (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Jan 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Columbia Suicide Severity Rating Scale (C-SSRS)
5.4; 8.4 .153
SECONDARY
Perceived Treatment Beliefs (PTS)
135.7; 133.04 .627
SECONDARY
Patient Health Questionnaire-9 (PHQ-9)
6.4; 12.3 <.001 sig
SECONDARY
Insomnia Severity Index (ISI)
7.9; 17.8 <.001 sig

Summary

There is a strong association between sleep disturbance and suicidal thoughts and behaviors. Sleep disturbance is also highly comorbid with other common conditions associated with suicide such as depression and posttraumatic stress disorder. Accordingly, this application focuses on improving sleep as a novel suicide prevention strategy that can be delivered to a broad range of Veterans. This pilot proposal specifically examines how Cognitive Behavioral Therapy for Insomnia, an efficacious treatment for insomnia, may reduce suicidal ideation in Veterans who also suffer from additional conditions. The proposal further suggests that adding this sleep intervention to usual care may further enhance overall care by increasing the utilization of recommended treatments for depression and posttraumatic stress disorder.

Eligibility Criteria

Inclusion Criteria

  • English speaking male and female Veterans ages 18-70;
  • demonstrate an understanding of the informed consent;
  • seeking or receiving services at the Canandaigua VA Medical Center (VAMC) or Rochester Outpatient Clinic;
  • endorse death/suicidal ideation on the Columbia Suicide Severity Rating Scale
  • either (i) a current diagnosis in their medical record of Major Depressive Disorder, Depression not otherwise specified, PTSD,or (ii) evidence of current depression as indicated by a score of > 10 on the Patient Health Questionnaire (PHQ-9) or current PTSD as indicated by a score of > 38 on the PTSD Symptom Checklist (PCL-5)();
  • have an Insomnia Severity Index score > 10 indicating clinically meaningful insomnia with at least 1 insomnia-related daytime consequence (score of 1 on item #3) and trouble sleeping 3 months

Exclusion Criteria

  • history of serious mental illness such as schizophrenia, Bipolar I or II disorder, or current psychiatric conditions such as psychosis, mania, dementia, cognitive impairment, OR suicidal ideation with plan and intent, a report of a suicide attempt in the past 6 months in the Computerized Patient Record System (CPRS) or via self-report, or a score of 4 on the Columbia-Suicide Severity Rating Scale
  • currently engaged in inpatient or partial hospitalization programs or ongoing/pending medical procedures that could inhibit sleep
  • recent substance dependence disorder with < 3 months in remission or abstinence;
  • suspicion of or evidence of untreated sleep apnea.
  • Diagnosis of a circadian rhythm disorder
  • Diagnosis of Narcolepsy
  • History of Seizures
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02248675). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search